Drug intelligence / Profile preview

Allergovac Hymenoptera

Development stage
Unknown
Lead developer
Roxall Medizin
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Allergovac Hymenoptera is a subcutaneous venom immunotherapy product containing standardized Hymenoptera venoms (typically honey bee Apis mellifera and vespid species such as Vespula spp. and Polistes dominula) used for desensitization of patients with IgE-mediated hymenoptera venom allergy who are at risk of systemic anaphylactic reactions to stings. The preparation consists of purified venom extracts formulated for gradual up‑dosing to a maintenance dose (usually around 100 µg of venom) in order to shift the immune response from an IgE‑mediated, mast cell–activating profile toward a more tolerogenic, IgG4‑dominated and T‑regulatory cell–associated response, thereby markedly reducing the risk and severity of systemic reactions upon subsequent natural stings.[1][3][9][11][12]

Brand names
Allergovac Hymenoptera
Other names
Allergovac Himenopteros
02

Targets

Honey bee venom allergens

Beyond the preview

Go deeper on Allergovac Hymenoptera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergovac Hymenoptera.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call